Sunday, April 12, 2026

Clear Press

Trusted · Independent · Ad-Free

Nationwide Recall Issued for Dietary Supplements Over Undeclared Allergens

Thousands of bottles sold across 40 states contain egg, soy, and hazelnut not listed on labels, FDA warns.

By Thomas Engel··2 min read

Federal health officials have issued a recall for thousands of bottles of dietary supplements distributed across 40 states after discovering the products contain undeclared allergens that could pose serious health risks to consumers with food sensitivities.

The U.S. Food and Drug Administration announced the recall on April 11, 2026, citing the presence of egg, soy, and hazelnut ingredients that were not disclosed on product labels, as reported by KFOR News. For individuals with allergies to these common food allergens, consumption could trigger reactions ranging from mild discomfort to life-threatening anaphylaxis.

Growing Concern Over Supplement Labeling

The recall highlights ongoing challenges in dietary supplement regulation and quality control. Unlike prescription medications, supplements face less stringent pre-market testing requirements, placing greater responsibility on manufacturers to ensure accurate labeling and allergen disclosure.

Food allergies affect approximately 32 million Americans, according to Food Allergy Research & Education, with reactions to eggs, soy, and tree nuts like hazelnuts among the most common. These allergens are required by federal law to be clearly identified on all food and supplement labels under the Food Allergen Labeling and Consumer Protection Act.

The nationwide distribution across 40 states suggests the affected products reached retail chains, health food stores, and potentially online marketplaces before the contamination was identified. The FDA has not yet specified which states received the recalled supplements or how the undeclared allergens entered the production process.

What Consumers Should Do

Anyone who has purchased dietary supplements recently should check their bottles against the FDA's recall list and examine ingredient labels carefully. Consumers with known allergies to egg, soy, or hazelnut should stop using any supplements that match the recalled products immediately.

The FDA recommends that individuals who have consumed the affected supplements and experienced allergic reactions report their adverse events through the agency's MedWatch program. This reporting system helps regulators identify patterns and take swift action to protect public health.

Retailers are expected to remove the recalled products from shelves, though the speed of such removals can vary. Consumers who purchased the supplements may be eligible for refunds by contacting the manufacturer or returning products to their point of purchase.

This incident serves as a reminder that dietary supplements, while widely available and marketed as natural health products, require the same careful attention to ingredient lists and potential allergens as conventional foods. For the estimated one in ten Americans living with food allergies, vigilance in reading labels remains essential—even when those labels should have been accurate from the start.

More in world

World·
Peru's Fractured Democracy: 35 Candidates Compete as Political Crisis Deepens

With three presidents ousted since 2021, Sunday's election reflects a nation searching for stability amid profound institutional breakdown.

World·
Canada's Liberal Leader Carney Calls for Unity as Party Eyes Majority Government

In closing speech at Montreal convention, incoming prime minister urges party to look beyond partisan divisions amid looming electoral victory.

World·
Asha Bhosle, Voice of Bollywood's Golden Era, Dies at 92

The legendary playback singer recorded over 12,000 songs across seven decades, defining the sound of Indian cinema for multiple generations.

World·
Asha Bhosle, Voice of a Billion Dreams, Dies at 92

The legendary playback singer who defined Bollywood's sound for seven decades leaves behind an unmatched legacy of music that transcended borders.

Comments

Loading comments…